MMRF CureCloud Research Initiative
Reason given: The MMRF has learned of the limitations of using a blood sample to collect genomic data, compared to a bone marrow aspirate. We decided that our resources are best served in other areas at this time.
Key facts
- Where
- Dallas, Hackensack, Norwalk, and St Louis, United StatesSee the 4 sites
Where in United States
- University of Texas Southwestern Medical CenterDallas, United StatesNo longer taking part
- Hackensack University Medical CenterHackensack, United StatesNo longer taking part
- Multiple Myeloma Research FoundationNorwalk, United StatesNo longer taking part
- Washington University Medical CampusSt Louis, United StatesNo longer taking part
Trial details
- Who runs it
- Multiple Myeloma Research Foundation
- Trial code
- NCT03657251
- Record updated
- 5 January 2024
- Original description
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.Read full original descriptionShow less
The MMRF CureCloud Multiple Myeloma Research Initiative
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.
Inclusion: Patients diagnosed with active Multiple Myeloma; Patients have signed an online consent form.
Exclusion: Patients who live outside the United States; Patients with a diagnosis other than Multiple Myeloma or a known or suspected precursor to Multiple Myeloma.